How do activation of glucocorticoid receptor-deficient T-cells and dysregulation of COX-2 activity cause mortality? Histological analyses of TGRKO and control mice treated with antibody to CD3ε ...
ABBV-154, an antibody-drug conjugate comprising adalimumab conjugated to a proprietary glucocorticoid receptor modulator, shows potential for extending flare-free periods in patients with ...
activity by glucocorticoid hormone," Cell, 62:1189-1204, 1990. Helmut Ponta (Kernforschungs-zentrum Karlsruhe, Germany): "Our paper was the first in a series that show that members of the steroid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback